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Catabolic pathways for naturally occurring, mostly plant-derived aromatic compounds are widely distributed in soil bacteria. Human-made xenobiotic compounds, in contrast, have been in the biosphere for only a few decades, but bacteria able to degrade such compounds have already been isolated. This demonstrates that under selective pressure exerted by pollutants, microbes can develop the capacity to degrade recalcitrant xenobiotics. For example, the ability to recognize and metabolize nitroaromatics by microorganisms might have been evolved only recently, since many nitroaromatic compounds are synthetic and have been introduced into the environment a short time ago ([@B1]). This process is still ongoing and therefore provides a good model for studying mechanisms of evolutionary processes in real time.

New catabolic pathways can evolve rapidly in bacteria as a result of horizontal gene transfer and point mutations that broaden the substrate range of preexisting enzymes ([@B2][@B3][@B7]). Mutational processes are the driving forces of evolution, and their rates fundamentally determine evolvability. The spontaneous mutation rate is generally held at a low level because most mutations are likely to be deleterious ([@B8]). However, bacterial populations with higher mutation rates can adapt to novel environments faster than those with lower mutation rates ([@B9]). Under certain circumstances, the frequency of mutations can be temporarily elevated. For example, accumulation of oxidative or alkylation damage in bacterial cells ([@B10][@B11][@B12]) and/or induction of the specific low-fidelity DNA polymerases when DNA is damaged can temporarily elevate the mutation rate ([@B13], [@B14]).

When present at a high concentration in cells, reactive oxygen species (ROS) have harmful effects on biological macromolecules such as proteins and nucleic acids ([@B15]). As mentioned above, oxidative damage to DNA is an important source of genetic variations ([@B12]). The classic strategy for the degradation of aromatic compounds comprises an attack by oxygenases that hydroxylate and finally cleave the aromatic ring with the help of activated molecular oxygen ([@B16]). Oxygenases can produce ROS by uncoupling of their catalytic mechanism ([@B17]). Moreover, it has been suggested that the ROS levels are further increased when oxygenases act on substrates that do not fit well in the active enzyme center ([@B18]). Thus, the evolution of new aerobic degradation pathways for xenoaromatic compounds could be associated with intracellular ROS generation, leading to elevated mutation frequency in cells.

A few years ago, Pérez-Pantoja and colleagues from Victor de Lorenzo's laboratory reported that the first enzyme for the 2,4-dinitrotoluene (2,4-DNT) degradation pathway identified in *Burkholderia* sp. was not yet optimal for DNT degradation ([@B7]). Phylogenetic analysis of the *dnt* gene cluster encoding DNT biodegradation indicated that 2,4-DNT dioxygenase DntA, which catalyzes the initial oxidation of DNT, has been evolved from naphthalene dioxygenase ([@B7], [@B19]). However, the growth of bacteria on 2,4-DNT was associated with generation of high levels of ROS and an elevated mutation frequency ([@B7]). The production of ROS was associated with a faulty DNT dioxygenation reaction of DntA, which was no longer optimal for naphthalene nor entirely advantageous yet for DNT oxidation. Thus, the observations of this study provided a very good example of how the faulty dioxygenation reaction of the evolving enzyme elevates mutation frequency in the presence of new xenobiotic substrate and thereby accelerates evolution of the degradation pathway of this substrate.

In an article in *mBio*, Akkaya and colleagues ([@B20]) have further elucidated molecular mechanisms of evolution of xenobiotic degradation pathways by addressing the effect of the background biochemical network on the evolvability of environmental bacteria hosting a new catabolic pathway. The *dnt* genes encoding biodegradation of 2,4-DNT in *Burkholderia* sp. were introduced into the genome of a Pseudomonas putida KT2440 derivative which was previously designed for improved genetic stability and better heterologous gene expression ([@B21][@B22][@B23]). The effect of 2,4-DNT catabolism on intracellular ROS production, redox stress, and genetic variability was assessed in the engineered P. putida strain EM·DNT. It appeared that 2,4-DNT degradation resulted in ROS generation and activation of cellular response to oxidative stress. At the same time, the frequency of mutations was not significantly increased. This raised the question of what are the mechanisms by which P. putida avoids the increased rate of mutagenesis in the presence of ROS.

The answer may lie in high production of NADPH that protects/stabilizes the P. putida redox state. NADPH is an essential electron donor in all organisms. NADPH provides the reducing power that drives various anabolic reactions, including those responsible for the biosynthesis of all major cell components ([@B24]). NADPH is also necessary in providing reducing equivalents to regenerate antioxidative defense systems following ROS detoxification ([@B25]). For example, regeneration of reduced forms of glutathione and thioredoxin, which offer a first line of defense against ROS, utilizes NADPH as the cofactor. Observations made in the soil bacterium Pseudomonasfluorescens show that redirection of metabolic pathways toward routes that regenerate reducing power (e.g., NADPH) plays an important role in removal of ROS ([@B26][@B27][@B28]). Traditionally, the dehydrogenases directly coupled to central carbon metabolism (e.g., the oxidative pentose phosphate \[PP\] pathway, the Entner-Doudoroff \[ED\] pathway, and the isocitrate dehydrogenase step of the tricarboxylic acid \[TCA\] cycle) are involved in NADPH generation, but other NADPH-generating enzymes (e.g., transhydrogenases, ferredoxin NADP^+^ oxidoreductases, and NAD^+^ and NADH kinases) also play an important role in the redox homeostasis ([@B24]). P. putida KT2440 is a soil bacterium with a remarkable metabolic diversity, which enables it to degrade a wide variety of natural and recalcitrant aromatic compounds, whereas the presence of the ED pathway along with activities of the incomplete Embden-Meyerhof-Parnas (EMP) and PP pathways (EDEMP cycle) helps to counteract both exogenous and endogenous oxidative stress ([@B29], [@B30]). As the EDEMP cycle produces larger amounts of NADPH, it has been hypothesized that this provides an explanation of why pseudomonads are frequent hosts of operons that encode strong oxidative enzymes for biodegradation of aromatic pollutants ([@B29], [@B31]). Moreover, it was recently demonstrated that P. putida KT2440 encodes two nucleotide transhydrogenases that preserve the redox balance of bacteria during biodegradation of aromatic pollutants ([@B32]).

As the redox status of P. putida cells influences their sensitivity to ROS, which in turn could affect mutagenic processes, Akkaya et al. ([@B20]) decided to alter the redox status of bacteria in order to investigate the relationship between the redox status and the mutation frequency in P. putida EM·DNT. Indeed, the mutagenic effect of the 2,4-DNT degradation pathway was evident when the redox status of P. putida EM·DNT was artificially perturbed by overproducing an NADH oxidase (Nox) from Streptococcus pneumoniae. Furthermore, comparison of the spectrum of Rif^r^ mutations occurring in the *rpoB* gene revealed that the frequency of the occurrence of C-to-A transversions was significantly increased in the Nox-overexpressing P. putida cells in the presence of 2,4-DNT. 8-OxoG (GO) is known to be one of the most stable and frequent base modifications caused by oxygen radical attack on DNA ([@B11]). In order to mitigate the mutagenic effect of 8-oxoG, bacteria have developed an oxidized guanine (GO) repair system ([@B33]). The impairment of the GO repair system results in enhanced production of G·C-to-T·A transversions ([@B34]). Hence, the results from the work of Akkaya et al. ([@B20]) indicate that mutation rate can be affected by the endogenous redox status of the corresponding cells, whereas the increased mutagenesis in cells with decreased redox power is connected with DNA damage caused by ROS. Compared to the 2,4-DNT mutagenic effects observed in *Burkholderia* sp., the more reductive redox status in P. putida could provide effective protection against this mutagenic effect.

Taken together, this is an elegant study which demonstrates that the redox status of cells affects evolvability of P. putida toward novel xenobiotic substrates. In addition to biodegradation applications, P. putida is also employed as a cell factory in synthetic biology (for recent reviews, see, e.g., references [@B31], [@B35], and [@B36]). From the work of Akkaya and colleagues, synthetic biologists can understand that achieving long-term stability of engineered producer strains requires cultivation of bacteria in a regime associated with high-level NADPH generation and ROS detoxification, whereas genetic diversification could be accelerated due to mutagenicity of ROS under conditions when NADPH becomes limiting. Thus, besides contributing to understanding mechanisms of evolutionary processes of new catabolic pathways, this knowledge might be important for bioengineering of P. putida with the purpose of bioproduction of value-added chemicals. Many natural products of industrial importance are complex secondary metabolites, the production of which often involves NADPH-dependent enzymes ([@B24]). As the synthesis of toxic chemicals could be associated with increased amounts of ROS and genetic instability of the engineered strains, the knowledge of connections between metabolism and evolvability of bacteria should be exploited for the rational design and operation of cell factories.

For the article discussed, see https://doi.org/10.1128/mBio.01512-18.
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